Tech Company Financing Transactions
Othera Pharmaceuticals Funding Round
Othera Pharmaceuticals closed a $3 million Series B funding round on 10/22/2004. Backers included Fletcher Spaght Ventures.
Transaction Overview
Company Name
Announced On
10/22/2004
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series B
Investors
Proceeds Purpose
the additional funding from this final closing will allow us to explore some new potential indications for OT-551 in the years ahead.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Four Tower Bridge 200 Barr Harbor Drive 400
Conshohocken, PA 19428
USA
Conshohocken, PA 19428
USA
Phone
Website
Email Address
Overview
Othera Pharmaceuticals, Inc. is a privately-held U.S. specialty pharmaceutical company focused on the development of innovative new drugs to treat the leading causes of blindness and vision impairment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Joseph
Vice President
Al Reaves
VP - Bus. Development
Philip Heifetz
VP - R & D
Ghanshyam Patil
Browse more venture capital transactions:
Prev: 10/21/2004: Escape Rescue Systems venture capital transaction
Next: 10/25/2004: IronPort Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs